Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1372295/full |
| _version_ | 1797337227850678272 |
|---|---|
| author | Barbara Castelli Barbara Castelli Carla Fonte Milena Guidi Milena Guidi Marco Tellini Marco Di Nicola Alessandro Iacono Anna Maria Buccoliero Daniela Greto Lorenzo Genitori Iacopo Sardi |
| author_facet | Barbara Castelli Barbara Castelli Carla Fonte Milena Guidi Milena Guidi Marco Tellini Marco Di Nicola Alessandro Iacono Anna Maria Buccoliero Daniela Greto Lorenzo Genitori Iacopo Sardi |
| author_sort | Barbara Castelli |
| collection | DOAJ |
| first_indexed | 2024-03-08T09:06:27Z |
| format | Article |
| id | doaj.art-7f49ae24c24e4f90ad68086bd303de89 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-08T09:06:27Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-7f49ae24c24e4f90ad68086bd303de892024-02-01T04:44:04ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-02-011410.3389/fonc.2024.13722951372295Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case reportBarbara Castelli0Barbara Castelli1Carla Fonte2Milena Guidi3Milena Guidi4Marco Tellini5Marco Di Nicola6Alessandro Iacono7Anna Maria Buccoliero8Daniela Greto9Lorenzo Genitori10Iacopo Sardi11Health Sciences Department, University of Florence, Florence, ItalyNeuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyNeuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyHealth Sciences Department, University of Florence, Florence, ItalyNeuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyNeuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyNeuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyRadiology Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyPathology Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyRadiotherapy Unit, University of Florence, Florence, ItalyNeurosurgery Unit, Meyer Children’s Hospital IRCCS, Florence, ItalyNeuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italyhttps://www.frontiersin.org/articles/10.3389/fonc.2024.1372295/fulllow-grade gliomasbevacizumabirinotecanpilocytic astrocytomacase report |
| spellingShingle | Barbara Castelli Barbara Castelli Carla Fonte Milena Guidi Milena Guidi Marco Tellini Marco Di Nicola Alessandro Iacono Anna Maria Buccoliero Daniela Greto Lorenzo Genitori Iacopo Sardi Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report Frontiers in Oncology low-grade gliomas bevacizumab irinotecan pilocytic astrocytoma case report |
| title | Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report |
| title_full | Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report |
| title_fullStr | Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report |
| title_full_unstemmed | Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report |
| title_short | Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report |
| title_sort | corrigendum bevacizumab irinotecan combination therapy in recurrent low grade glioma previously treated with chemo radiotherapy a case report |
| topic | low-grade gliomas bevacizumab irinotecan pilocytic astrocytoma case report |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2024.1372295/full |
| work_keys_str_mv | AT barbaracastelli corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT barbaracastelli corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT carlafonte corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT milenaguidi corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT milenaguidi corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT marcotellini corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT marcodinicola corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT alessandroiacono corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT annamariabuccoliero corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT danielagreto corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT lorenzogenitori corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport AT iacoposardi corrigendumbevacizumabirinotecancombinationtherapyinrecurrentlowgradegliomapreviouslytreatedwithchemoradiotherapyacasereport |